Riled By Schering-Plough Case, Senators Introduce Bill

Law360, New York (June 28, 2006, 12:00 AM EDT) -- Four top Senate judiciary committee members are taking matters into their own hands and introducing legislation to prohibit brand-name drug makers from paying rivals to keep generic drugs off the market.

The move comes in reaction to the U.S. Supreme Court’s refusal to hear the U.S. Federal Trade Commission’s appeal in the closely watched Schering-Plough case.

“When big brand-name drug companies pay generic manufacturers to stop generic drugs from reaching pharmacy shelves, consumers lose big-time,” said Sen. Herb Kohl (D-Wis.). “These companies are playing it fast-and-loose...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.